Tada good point. We are still waiting to hear what adjustments will be made to the BETonMACE trial to include USA patients. So the original planned enrollment of 2400 patients to be enrolled by Fall 2017 may be revised to a higher enrollment target and of course take longer to complete enrollment. But if the 2400 remains unchanged though, then the USA patients will need to squeeze into the remaining 600. Sure would be nice to know what is going on here. Hint.....hint....RVX managementÂ
BearDownAZÂ
